Skip to main content
Caplight Logo









Deep Apple Therapeutics

Deep Apple Therapeutics

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://deepappletx.com/

Last Round

Series A

Dec 14, 2023

Total Funding Raised

$52M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Deep Apple Therapeutics is a biotechnology company that develops small-molecule drugs for inflammatory, metabolic, and endocrine diseases using a proprietary discovery engine that integrates cryo-electron microscopy, deep learning, and virtual screening.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryAI drug discoverybiotechmetabolic diseaseAI-first biotechsmall-molecule researchdrug discovery platformtherapeutic candidatesnon-GLP-1structure-based discoveryweight-loss drugspharma licensingin silico drug designmolecular dynamicscryo-EM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Apple Therapeutics Comparables

Compare Deep Apple Therapeutics with similar companies based on industry and business-model similarity.

Deep Apple Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Superluminal Medicines
83%
Terray Therapeutics
79%
Kallyope
76%

Deep Apple Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 14, 2023

Deep Apple Therapeutics Investors

Notable investors and investment history

Deep Apple Therapeutics investors
InvestorRounds
Apple Tree PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 120% MoM, reaching 5K.

  • Jul 25, 2026

    Monthly visitors increased 250% MoM.

Deep Apple Therapeutics Filings

Explore SEC and related filing metadata, where available.

Deep Apple Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Deep Apple Therapeutics's valuation, stock price, and market status.

Is Deep Apple a public or private company?

Deep Apple is a private company.

What is the current stock price of Deep Apple?

Deep Apple is a private company with no public stock price. No recent secondary market data is available.

How much is Deep Apple worth (valuation)?

Valuation information for Deep Apple is not publicly available.

Can I buy Deep Apple stock?

Deep Apple shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Deep Apple's last funding round?

Deep Apple's most recent funding round was Series A on December 14, 2023.

Who are the main investors in Deep Apple?

Key investors in Deep Apple include Apple Tree Partners.

Will Deep Apple IPO soon?

No public IPO plans have been announced for Deep Apple.

How can I track Deep Apple secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deep Apple's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range24
Year Founded2022
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?